| Identification | Back Directory | [Name]
1,2-Cyclopentanediol, 3-(4-amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-[2-[[[(3-fluorobicyclo[1.1.1]pent-1-yl)methyl]amino]methyl]-1H-indol-6-yl]-, (1R,2S,3R,5R)- | [CAS]
2767003-71-2 | [Synonyms]
METTL3-IN-3
1,2-Cyclopentanediol, 3-(4-amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-[2-[[[(3-fluorobicyclo[1.1.1]pent-1-yl)methyl]amino]methyl]-1H-indol-6-yl]-, (1R,2S,3R,5R)- | [Molecular Formula]
C26H28BrFN6O2 | [MOL File]
2767003-71-2.mol | [Molecular Weight]
555.44 |
| Hazard Information | Back Directory | [Uses]
METTL3-IN-3 (compound 11) is a polyheterocyclic compound, acts as METTL3 inhibitor[1]. | [References]
[1] Blackaby WP, et al. Preparation of polyheterocyclic compounds as METTL3 inhibitors: World Intellectual Property Organization, WO2021111124[P]. 2021-06-10.
[2] Zeng C, et al. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol. 2020 Aug 27;13(1):117. DOI:10.1186/s13045-020-00951-w |
|
|